Search clinical trials for: EGFR inhibitor-sensitive mutation
Total 4290 results
-
Thomas Jefferson UniversityCompletedStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Health Care Provider | Activating ALK Gene Mutation Negative | Activating EGFR Gene Mutation Negative | Activating ROS1 Gene Mutation NegativeUnited States
-
ETOP IBCSG Partners FoundationSpanish Lung Cancer GroupCompletedLung CancerSpain, Ireland, United Kingdom, Switzerland, France, Germany, Greece, Italy
-
National Taiwan University HospitalCompletedTumor Progression | EGFR Exon 19 MutationTaiwan
-
Checkpoint Therapeutics, Inc.CompletedLung Diseases | Adenocarcinoma | Carcinoma, Non-Small-Cell Lung | Lung NeoplasmsUnited States, Thailand, New Zealand, Australia, Poland
-
Sunshine Lake Pharma Co., Ltd.Active, not recruitingNon-small Cell Lung CancerChina
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Active, not recruitingNon-small Cell Lung CancerChina
-
National Cancer Centre, SingaporeTerminatedNon-small Cell Lung Cancer | Leptomeningeal Disease | Central Nervous System MetastasesSingapore
-
Spanish Lung Cancer GroupCompletedNon-Small Cell Lung CancerSpain, France, Italy
-
Fundación GECPCompletedNon Small Cell Lung CancerSpain
-
Beta Pharma ShanghaiCompleted
-
Beta Pharma ShanghaiCompletedNon-small Cell Lung CancerChina
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedNon-Small Cell Lung CarcinomaUnited States
-
National Cancer Center, KoreaHoffmann-La RocheActive, not recruitingNSCLC Stage II | NSCLC, Stage IIIAKorea, Republic of
-
AstraZenecaTerminated
-
Sihuan Pharmaceutical Holdings Group Ltd.Covance; XuanZhu Pharma Co., Ltd.CompletedAdvanced Solid TumorsUnited States
-
Betta Pharmaceuticals Co., Ltd.CompletedNon-small Cell Lung CancerChina
-
Chul KimBristol-Myers Squibb; AstraZeneca; Walter Reed National Military Medical Center; Hackensack Meridian HealthActive, not recruitingNonsmall Cell Lung Cancer | EGFR Gene MutationUnited States
-
Central Hospital, Nancy, FranceInstitut de Cancérologie de LorraineEnrolling by invitationLung Cancer | Non Small Cell Lung Cancer | Lung Adenocarcinoma | KRAS Mutation-Related Tumors | EGFR Activating MutationFrance
-
AstraZenecaParexelCompletedLung CancerCanada, Denmark, Italy, Spain, Belgium, Korea, Republic of, Brazil, China, Taiwan, Australia, Austria, United Kingdom, Sweden, Argentina, Saudi Arabia, Ireland
-
Centre Oscar LambretUniversity Hospital, LilleTerminated
-
Exosome Diagnostics, Inc.Active, not recruitingCarcinoma, Non-Small-Cell LungUnited States
-
Seoul National University HospitalAstraZeneca; Korean Cancer Study GroupCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of
-
Samsung Medical CenterActive, not recruitingNon-Small Cell Lung Cancer With EGFR T790M Mutation | With Brain and/or Leptomeningeal Metastasis | Failed Tyrosine Kinase InhibitorsKorea, Republic of
-
Yuhan CorporationActive, not recruitingEGFR Gene MutationKorea, Republic of
-
Chonnam National University HospitalCompletedLung Neoplasms | EGFR Gene MutationsKorea, Republic of
-
Chonnam National University HospitalRoche Pharma AGCompletedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentKorea, Republic of
-
Chonnam National University HospitalCompletedLung Neoplasms | EGFR Gene MutationKorea, Republic of
-
Betta Pharmaceuticals Co., Ltd.Active, not recruitingNon-small Cell Lung CancerChina
-
Korea University Guro HospitalChong Kun Dang Pharmaceutical Corp.Active, not recruitingEGFR Positive Non-small Cell Lung CancerKorea, Republic of
-
Grupo Español de Investigación en NeurooncologíaPfizerCompleted
-
Spectrum Pharmaceuticals, IncTerminated
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Australia, Japan
-
National Cancer Centre, SingaporeCompletedNon-small Cell Lung CancerSingapore
-
AstraZenecaiOMEDICO AG, Freiburg, GermanyCompletedCarcinoma, Non-Small-Cell LungGermany
-
Tianjin Medical University Cancer Institute and...Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedNon Small Cell Lung CancerChina
-
European Organisation for Research and Treatment...Active, not recruitingEGFR Mutation Positive Non Small Cell Lung CancerUnited Kingdom
-
Sun Yat-sen UniversityEnrolling by invitation
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | EGFR Activating MutationUnited States
-
Hanmi Pharmaceutical Company LimitedTerminatedNon Small Cell Lung CancerUnited States, Australia, Italy, Korea, Republic of, Spain, Germany, Malaysia, Taiwan, Canada, Philippines
-
AstraZenecaCompletedEGFR Mutation Positive Advanced Non Small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Australia
-
Hellenic Cooperative Oncology GroupCompletedNon Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | EGFR Gene Mutation
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Boehringer IngelheimCompletedLung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
Shandong Cancer Hospital and InstituteChia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownNon Small Cell Lung CancerChina
-
Hanmi Pharmaceutical Company LimitedTerminatedNSCLCKorea, Republic of, China
-
Fudan UniversityUnknownLung Cancer, Non-small Cell | EGFR Gene Mutation | EGFR T790MChina
-
PfizerCompletedSolid Tumor | Unspecified Adult Solid Tumor, Protocol SpecificUnited States, Australia, Canada, France, Spain
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedLung Non-Squamous Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7 | EGFR Exon 19 Deletion Mutation | EGFR NP_005219.2:p.L858RUnited States
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
Shanghai Cancer Hospital, ChinaUnknownLung Cancer Stage IV，EGFR-mutant，TKI，PD-L1，SBRTChina